(RNA) Avidity Biosciences - Performance -20.8% in 12m
RNA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-8.73%
#40 in Peer-Group
Rel. Strength
23.68%
#5806 in Stock-Universe
Total Return 12m
-20.78%
#78 in Peer-Group
Total Return 5y
8.55%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 52.50 USD |
| 52 Week Low | 24.08 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 32.26 |
| Buy/Sell Signal +-5 | -0.27 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RNA (-20.8%) vs XBI (-7.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
10.4% | 76.6% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.77% | -4.62% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
9.62% | 0.48% | 57% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
2.27% | 33.8% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.43% | -8.06% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
13.1% | 44.8% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
0.29% | 36.9% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
8.57% | 17.2% | 11.2% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: RNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RNA
| Total Return (including Dividends) | RNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.28% | 7.76% | 1.11% |
| 3 Months | -7.27% | -5.31% | 5.58% |
| 12 Months | -20.78% | -7.58% | 10.51% |
| 5 Years | 8.55% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | RNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 73.8% | 84.2% | 69.9% |
| 3 Months | 31.5% | -2.8% | 69.3% |
| 12 Months | -72.9% | -77.8% | 43.2% |
| 5 Years | 11.6% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #105 | 0.49% | 7.10% |
| 3 Month | #105 | -2.08% | -12.17% |
| 12 Month | #79 | -14.29% | -28.32% |
| 5 Years | #38 | 33.27% | -48.09% |
FAQs
Does Avidity Biosciences (RNA) outperform the market?
No,
over the last 12 months RNA made -20.78%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.58%.
Over the last 3 months RNA made -7.27%, while XBI made -5.31%.
Performance Comparison RNA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RNA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.5% | 7.2% | -5.1% | -31% |
| US NASDAQ 100 | QQQ | -3.3% | 6.8% | -4.3% | -30% |
| German DAX 40 | DAX | -1.3% | 9% | -21.4% | -50% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.2% | 9.2% | -6.9% | -32% |
| Hongkong Hang Seng | HSI | -4% | 3.2% | -24.1% | -48% |
| India NIFTY 50 | INDA | -1.8% | 9.6% | -4% | -19% |
| Brasil Bovespa | EWZ | -5.8% | 7.8% | -25.3% | -30% |
RNA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.2% | 6.8% | -7.9% | -44% |
| Consumer Discretionary | XLY | -3% | 10.1% | 4.8% | -39% |
| Consumer Staples | XLP | -3.2% | 8.5% | -6.5% | -28% |
| Energy | XLE | -9.4% | 5.4% | -8.7% | -24% |
| Financial | XLF | -1.9% | 10.9% | -7.9% | -45% |
| Health Care | XLV | -5.4% | 3.9% | -4.6% | -16% |
| Industrial | XLI | -2.5% | 7.9% | -10.6% | -39% |
| Materials | XLB | -2.8% | 6.9% | -5.8% | -20% |
| Real Estate | XLRE | -4% | 7.3% | -6.1% | -34% |
| Technology | XLK | -3.8% | 6.3% | -5.5% | -25% |
| Utilities | XLU | -4.9% | 7.8% | -13.4% | -42% |
| Aerospace & Defense | XAR | -2.5% | 2.5% | -22% | -63% |
| Biotech | XBI | -3.2% | 0.5% | 5.7% | -13% |
| Homebuilder | XHB | -1.9% | 13.3% | 10.4% | -11% |
| Retail | XRT | 0.4% | 8.5% | 2.9% | -21% |
RNA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -15.3% | -10.4% | -14.9% | -24% |
| Natural Gas | UNG | -2.7% | 10.9% | -23.3% | -6% |
| Gold | GLD | -7.1% | 2.1% | -35.2% | -68% |
| Silver | SLV | -2.7% | -3.1% | -24.7% | -43% |
| Copper | CPER | -1% | 6.6% | -19.9% | -29% |
RNA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5% | 7.6% | -3.6% | -17% |
| iShares High Yield Corp. Bond | HYG | -4% | 7.8% | -8.7% | -30% |